Horn, Evelyn M.

Publications

Sort by

Co-Author Network

selected publications

Pulmonary artery compliance in different forms of pulmonary hypertension. Heart (British Cardiac Society). 2023 Academic Article GET IT
Times cited: 1
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients. European heart journal. 2023 Academic Article GET IT
Times cited: 20
Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications. European heart journal. 2023 Academic Article GET IT
Times cited: 2
Hidden Bias: The Intersection of Ageism and Gender in Adult Cardiology. JACC. Heart failure. 2023 Editorial Article GET IT
Impact of acute TTE-evidenced cardiac dysfunction on in-hospital and outpatient mortality: A multicenter NYC COVID-19 registry study. PloS one. 2023 Academic Article GET IT
Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association. Circulation. 2023 Review GET IT
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension. medRxiv : the preprint server for health sciences. 2023 Article GET IT
Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study. Pulmonary circulation. 2023 Academic Article GET IT
More COACHing Needed to Optimize Care after Heart Failure Hospitalization. The New England journal of medicine. 2023 Editorial Article GET IT
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry. Pulmonary circulation. 2022 Article GET IT
Direct comparison of echocardiography speckle tracking and cardiac magnetic resonance feature tracking for quantification of right ventricular strain: a prospective intermodality study in functional mitral regurgitation. Echo research and practice. 2022 Academic Article GET IT
Times cited: 89
Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR). The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022 Academic Article GET IT
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease. Journal of the American College of Cardiology. 2022 Academic Article GET IT
Times cited: 6
Post-operative atrial fibrillation and risk of heart failure hospitalization. European heart journal. 2022 Academic Article GET IT
Times cited: 4
Detecting early physiologic changes through cardiac implantable electronic device data among patients with COVID-19. Cardiovascular digital health journal. 2022 Academic Article GET IT
Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation. Heart rhythm O2. 2022 Academic Article GET IT
Times cited: 2
Corrigendum for health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry. Pulmonary circulation. 2022 Article GET IT
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022 Editorial Article GET IT
Times cited: 4
Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience. European heart journal. Cardiovascular Imaging. 2022 Academic Article GET IT
Times cited: 3
Remote Cardiac Monitoring in Patients With Heart Failure: A Review. JAMA cardiology. 2022 Review GET IT
Times cited: 13
Distinguishing exercise intolerance in early-stage pulmonary hypertension with invasive exercise hemodynamics: Rest V_E /VCO₂ and ETCO₂ identify pulmonary vascular disease. Clinical cardiology. 2022 Academic Article GET IT
Times cited: 3
Ruptured Sinus of Valsalva Aneurysm: An Unusual Cause of Heart Failure in a Young Woman. 2021 GET IT
Acute COVID-19-Associated Decrements in Left and Right Ventricular Function Predict All-Cause Mortality. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2021 Academic Article GET IT
Times cited: 4
Impact of hospital transfer to hubs on outcomes of cardiogenic shock in the real world. European journal of heart failure. 2021 Academic Article GET IT
Times cited: 10
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances. 2021 GET IT
Times cited: 37
Exception Status Listing in the New Adult Heart Allocation System: A New Solution to an Old Problem?. Circulation. Heart failure. 2021 Academic Article GET IT
Times cited: 9
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry. Pulmonary circulation. 2021 Academic Article GET IT
Times cited: 11
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2021 Review GET IT
Times cited: 10
Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry. American journal of respiratory and critical care medicine. 2021 Letter GET IT
Times cited: 10
Novel Echocardiographic Algorithm for Right Ventricular Mass Quantification: Cardiovascular Magnetic Resonance and Clinical Prognosis Validation. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2021 Academic Article GET IT
Pulmonary Hypertension in Pregnancy. Clinics in chest medicine. 2021 Review GET IT
Times cited: 5
Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non-Left Ventricular Assist Device Centers. Journal of the American Heart Association. 2020 Academic Article GET IT
Times cited: 4
Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19. Journal of the American College of Cardiology. 2020 Academic Article GET IT
Times cited: 67
Obesity in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR). Annals of the American Thoracic Society. 2020 Academic Article GET IT
Times cited: 10
Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19. Journal of cardiac failure. 2020 Academic Article GET IT
Times cited: 10
Transition of a Large Tertiary Heart Failure Program in Response to the COVID-19 Pandemic: Changes That Will Endure. Circulation. Heart failure. 2020 Academic Article GET IT
Times cited: 13
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. 2020 GET IT
Times cited: 85
United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis. Clinical transplantation. 2020 Academic Article GET IT
Times cited: 13
Obesity and COVID-19 in New York City: A Retrospective Cohort Study. Annals of internal medicine. 2020 Letter GET IT
Times cited: 59
Author rebuttal to response regarding "Letter to the Editor regarding 'Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?'". Pulmonary circulation. 2020 Academic Article GET IT
Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?. Pulmonary circulation. 2020 Academic Article GET IT
Clinical Characteristics of Covid-19 in New York City. The New England journal of medicine. 2020 Letter GET IT
Times cited: 1479
The Variety of Cardiovascular Presentations of COVID-19. 2020 GET IT
Times cited: 367
Association of Hospital Volume with 30-Day Readmission Following Left Ventricular Assist Device Implantation. Journal of cardiac failure. 2020 Letter GET IT
Relation of a Simple Cardiac Co-Morbidity Count and Cardiovascular Readmission After a Heart Failure Hospitalization. The American journal of cardiology. 2020 Academic Article GET IT
Times cited: 5
Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS Program. Circulation. Heart failure. 2020 Academic Article GET IT
Times cited: 17
Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation - initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2019 Academic Article GET IT
Times cited: 11
Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2019 Academic Article GET IT
Times cited: 9
Contribution of the left atrial remodeling to the elevated pulmonary capillary wedge pressure in patients with WHO Group II pulmonary hypertension. Journal of echocardiography. 2018 Academic Article GET IT
Times cited: 2
Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort. International journal of cardiology. 2018 Academic Article GET IT
Times cited: 25
Systemic blood pressure trends and antihypertensive utilization following continuous-flow left ventricular assist device implantation: an analysis of the interagency registry for mechanically assisted circulatory support. Journal of thoracic disease. 2018 Academic Article GET IT
Times cited: 226
Discharge Processes and 30-Day Readmission Rates of Patients Hospitalized for Heart Failure on General Medicine and Cardiology Services. The American journal of cardiology. 2018 Academic Article GET IT
Times cited: 11
Transcatheter Aortic Valve Replacement as a Bridge to Left Ventricular Assist Device Implantation. 2018 GET IT
Times cited: 1
PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics. Circulation research. 2017 Academic Article GET IT
Times cited: 80
Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?. Journal of the American Geriatrics Society. 2017 Academic Article GET IT
Times cited: 45
Characteristics of hospitalizations for cardiogenic shock after acute myocardial infarction in the United States. International journal of cardiology. 2017 Academic Article GET IT
Times cited: 8
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. 2017 GET IT
Times cited: 50
Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis. Autoimmunity reviews. 2017 Review GET IT
Times cited: 41
Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association. 2017 Academic Article GET IT
Times cited: 31
Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension. Rheumatology (Oxford, England). 2016 Academic Article GET IT
Times cited: 3
Patterns of scheduled follow-up appointments following hospitalization for heart failure: insights from an urban medical center in the United States. Clinical interventions in aging. 2016 Academic Article GET IT
Times cited: 6
A Contemporary Approach to Pulmonary Arterial Hypertension. Current atherosclerosis reports. 2016 Review GET IT
Times cited: 1
Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology. Cardiology clinics. 2016 Review GET IT
Times cited: 11
Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction. The American journal of medicine. 2016 Academic Article GET IT
Times cited: 72
An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature. 2016 GET IT
Association of Right Ventricular Pressure and Volume Overload with Non-Ischemic Septal Fibrosis on Cardiac Magnetic Resonance. PloS one. 2016 Academic Article GET IT
Times cited: 7
Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension. Annals of the American Thoracic Society. 2016 Academic Article GET IT
Times cited: 47
Pulmonary tumour thrombotic microangiopathy as a cause of new-onset pulmonary hypertension in a patient with metastatic low-grade serous ovarian cancer. 2015 GET IT
Times cited: 9
Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement. The Journal of thoracic and cardiovascular surgery. 2015 Academic Article GET IT
Times cited: 10
Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy). 2015 GET IT
Times cited: 33
Extracorporeal Membrane Oxygenation as a Bridge through Chemotherapy in B-Cell Lymphoma. 2015 GET IT
Times cited: 15
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension. Annals of the American Thoracic Society. 2015 Academic Article GET IT
Times cited: 29
Costs and in-hospital outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in commercial cases using a propensity score matched model. The American journal of cardiology. 2015 Academic Article GET IT
Times cited: 34
Outcomes of patients implanted with a left ventricular assist device at nontransplant mechanical circulatory support centers. The American journal of cardiology. 2015 Academic Article GET IT
Times cited: 15
Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging. The international journal of cardiovascular imaging. 2014 Academic Article GET IT
Times cited: 14
Functional mitral regurgitation: therapeutic strategies for a ventricular disease. Journal of cardiac failure. 2014 Review GET IT
Times cited: 19
Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis. Arthritis care & research. 2013 Academic Article GET IT
Times cited: 5
Extent and severity of coronary artery disease by coronary CT angiography is associated with elevated left ventricular diastolic pressures and worsening diastolic function. Journal of cardiovascular computed tomography. 2013 Academic Article GET IT
Times cited: 19
Preoperative assessment of high-risk candidates to predict survival after heart transplantation. Circulation. Heart failure. 2013 Academic Article GET IT
Times cited: 28
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2012 Review GET IT
Times cited: 183
Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis. European journal of heart failure. 2012 Academic Article GET IT
Times cited: 27
Pulmonary hypertension and right ventricular dysfunction in left heart disease (group 2 pulmonary hypertension). Progress in cardiovascular diseases. 2012 Review GET IT
Times cited: 13
Pulmonary vascular disease and the right ventricle. Introduction. Progress in cardiovascular diseases. 2012 Editorial Article GET IT
Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system. Progress in cardiovascular diseases. 2012 Review GET IT
Times cited: 42
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. Circulation. 2011 Academic Article GET IT
Times cited: 104
Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT. Contemporary clinical trials. 2010 Academic Article GET IT
Times cited: 8
Sarcoidosis-associated fibrosing mediastinitis with resultant pulmonary hypertension: a case report and review of the literature. Respiration; international review of thoracic diseases. 2009 Review GET IT
Times cited: 46
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. American journal of respiratory and critical care medicine. 2009 Academic Article GET IT
Times cited: 183
Physiologic determinants of mitral inflow pattern using a computer simulation: insights into Doppler echocardiography in diverse phenotypes. Echocardiography (Mount Kisco, N.Y.). 2009 Academic Article GET IT
Times cited: 1
Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest. 2009 Academic Article GET IT
Times cited: 31
Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. Chest. 2008 Academic Article GET IT
Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2008 Academic Article GET IT
Times cited: 29
Clinical risk factors for portopulmonary hypertension. Hepatology (Baltimore, Md.). 2008 Academic Article GET IT
Times cited: 204
Bloodstream infections in patients given treatment with intravenous prostanoids. Infection control and hospital epidemiology. 2008 Academic Article GET IT
Times cited: 81
Severe pulmonary hypertension due to chronic echinococcal pulmonary emboli treated with targeted pulmonary vascular therapy and hepatic resection. 2007 GET IT
Times cited: 8
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Annals of the rheumatic diseases. 2007 Academic Article GET IT
Times cited: 85
Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure. Transplantation. 2007 Academic Article GET IT
Times cited: 74
Plasma serotonin levels are normal in pulmonary arterial hypertension. Pulmonary pharmacology & therapeutics. 2007 Academic Article GET IT
Times cited: 25
Estimation of the optimal VV delay by an IEGM-based method in cardiac resynchronization therapy. Pacing and clinical electrophysiology : PACE. 2007 Academic Article GET IT
Times cited: 27
Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension. Pulmonary pharmacology & therapeutics. 2006 Academic Article GET IT
Times cited: 60
Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension. Expert review of cardiovascular therapy. 2005 Review GET IT
Times cited: 19
von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension. Chest. 2005 Academic Article GET IT
Times cited: 69
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascular pharmacology. 2005 Academic Article GET IT
Times cited: 138
New predictors of outcome in idiopathic pulmonary arterial hypertension. The American journal of cardiology. 2005 Academic Article GET IT
Times cited: 193
Significant left ventricular hypertrophy on SPECT imaging in a patient with hypertrophic cardiomyopathy: a comparative image with cardiac magnetic resonance. 2005 GET IT
Times cited: 2
Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension. Expert opinion on investigational drugs. 2004 Academic Article GET IT
Times cited: 15
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. The European respiratory journal. 2004 Academic Article GET IT
Times cited: 554
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. The European respiratory journal. 2004 Academic Article GET IT
Times cited: 94
Loss of left bundle branch block following biventricular pacing therapy for heart failure: evidence for electrical remodeling? 2004 GET IT
Times cited: 24
Sitaxsentan therapy for pulmonary arterial hypertension. American journal of respiratory and critical care medicine. 2003 Academic Article GET IT
Times cited: 660
Sitaxsentan in pulmonary arterial hypertension. Chest. 2003 Letter GET IT
Times cited: 3
Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations. The Journal of rheumatology. 2002 Academic Article GET IT
Times cited: 82
Treprostinil therapy for pulmonary artery hypertension. Expert opinion on investigational drugs. 2002 Review GET IT
Times cited: 11
Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. Chest. 2002 Academic Article GET IT
Times cited: 231
Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Journal of cardiac failure. 2000 Academic Article GET IT
Times cited: 151
Effects of beta-blockers on neurohormonal activation in patients with congestive heart failure. Drugs. 2000 Review GET IT
Times cited: 20
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest. 2000 Letter GET IT
Times cited: 24
Current management of patients with pulmonary hypertension and right ventricular insufficiency. Current cardiology reports. 2000 Review GET IT
Times cited: 1
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Annals of internal medicine. 2000 Academic Article GET IT
Times cited: 1006
Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33. American journal of respiratory and critical care medicine. 2000 Academic Article GET IT
Times cited: 82
Hormone replacement therapy: a possible risk factor in carriers of familial primary pulmonary hypertension. Chest. 1999 Letter GET IT
Times cited: 9
Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation. 1995 Academic Article GET IT
Times cited: 363
Lymphocyte G proteins reflect response to treatment in congestive heart failure. American heart journal. 1995 Academic Article GET IT
Times cited: 4
Effect of innervation on heart rate response to mental stress. Archives of general psychiatry. 1993 Academic Article GET IT
Times cited: 16
Beta-adrenergic receptor sensitivity and guanine nucleotide regulatory proteins in transplanted human hearts and autotransplanted baboons. Transplantation. 1991 Academic Article GET IT
Times cited: 8
The influence of detergents on the availability of pertussis toxin substrates. Archives of biochemistry and biophysics. 1991 Academic Article GET IT
Times cited: 6
Mechanisms of abnormal transmembrane signaling of the beta-adrenergic receptor in congestive heart failure. Circulation. 1990 Review GET IT
Times cited: 22
Developmental changes in the electrophysiological properties and the beta-adrenergic receptor-effector complex in atrial fibers of the canine coronary sinus. Circulation research. 1989 Academic Article GET IT
Times cited: 6
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy. Circulation. 1988 Academic Article GET IT
Times cited: 85
G protein-adrenergic interactions in the heart. Molecular and cellular biochemistry. 1988 Academic Article GET IT
Times cited: 4
Acute myocardial infarction during streptokinase therapy. 1987 GET IT
Adverse clinical and hemodynamic effects of oral levodopa in chronic congestive heart failure. 1985 GET IT
Times cited: 9

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Noninvasive measurement of oxygenation using quantitative susceptibility mapping awarded by National Heart, Lung, & Blood Institute Co-Investigator 2021 - 2025

Assessing the Utility of Submaximal Cardiopulmonary Exercise Testing in Diagnosis and Treatment Management of Pulmonary Arterial Hypertension awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2022 - 2024
Pulmonary Vascular Disease Phenomics Program (PVDOMICS) Data Coordinating Center awarded by National Institute on Aging Principal Investigator Subaward 2016 - 2023

more ...

less ...

Background

education and training

M.D., Mount Sinai School of Medicine 1980
B.S., Brown University 1976

Contact

full name

Evelyn M. Horn

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Evelyn M. Horn Professor of Clinical Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

webpage